Johansson L, Nowak P, Schröder R. "Method for the Synthesis of Empagliflozin impurity 202" [P]. European Patent, EP 3350160 A1, 2025-03-03.
发明人周伟,沈红梅,刘建华. "A Process for Preparing High-Purity Empagliflozin impurity 202" [P]. 中国发明专利, 专利号 CN 116290828 A, 授权公告日 2020-03-18.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质202 in Pharmaceutical Formulations". Anal. Methods, 2016, 397, (3), 2949-2957.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质202 as an Impurity". Sci. Total Environ., 2024, 1852, 1721-1744.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin impurity 202 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2013, 973, (1), 226-248.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 恩格列净杂质202 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2019, 742, (4), 7522-7547.